Literature DB >> 16581612

Uveal and conjunctival malignant melanoma in denmark 1943-97: observed and relative survival of patients followed through 2002.

P Isager1, G Engholm, J Overgaard, H Storm.   

Abstract

PURPOSE: To evaluate the observed and relative survival of patients diagnosed with a malignant melanoma in the ocular region in Denmark during the period 1943-97.
METHODS: The study included 2,504 patients (1,292 men and 1,212 women) diagnosed with a melanoma in the ocular region, of which 2,434 cases could be topographically subclassified into 2,178 in the choroid/ciliary body, 141 in the iris, and 115 in the conjunctiva. The patients were followed through 2002 and the observed survival proportions and relative survival ratios were estimated.
RESULTS: For the total ocular region and the choroid/ciliary body, the observed survival did not vary statistically significantly with the year of diagnosis. A statistically insignificant higher observed survival for women than men was found for tumors in the ocular region and the subgroups choroid/ciliary body, iris, and conjunctiva. During the 55-year study period, the 5- and 10-year relative survival remained stable for the ocular region for men at 67% and 57% and for women at 71% and 60%, respectively, and stable for the choroid/ciliary body for men at 66% and 55% and for women at 69% and 57%, respectively. The 5- and 10-year relative survival for the iris was for men 90% and 85% and for women 99% and 101%, respectively, and for the conjunctiva for men 83% and 70% and for women 93% and 82%, respectively.
CONCLUSION: The observed and relative survival of patients diagnosed with a melanoma in the ocular region and choroid/ciliary body in Denmark during the period 1943-97 and followed through 2002 has remained stable. The highest observed and relative survival was found for iris melanomas, the lowest for choroid/ciliary body melanomas, and intermediate for conjunctival melanomas.

Entities:  

Mesh:

Year:  2006        PMID: 16581612     DOI: 10.1080/09286580600553330

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  23 in total

1.  Management of conjunctival malignant melanoma: a review and update.

Authors:  James R Wong; Afshan A Nanji; Anat Galor; Carol L Karp
Journal:  Expert Rev Ophthalmol       Date:  2014-06

Review 2.  Conjunctival Melanoma - Epidemiological Trends and Features.

Authors:  Snježana Kaštelan; Antonela Gverović Antunica; Lidija Beketić Orešković; Jasminka Salopek Rabatić; Boris Kasun; Ivana Bakija
Journal:  Pathol Oncol Res       Date:  2018-05-25       Impact factor: 3.201

3.  Management of Conjunctival Melanoma: Critical Assessment of Sentinel Lymph Node Biopsy.

Authors:  Hassan A Aziz; Brian R Gastman; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2015-05-06

Review 4.  Ocular melanoma: an overview of the current status.

Authors:  Predrag Jovanovic; Marija Mihajlovic; Jasmina Djordjevic-Jocic; Slobodan Vlajkovic; Sonja Cekic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

5.  Incidence and Survival of Patients With Conjunctival Melanoma in Europe.

Authors:  Gianni Virgili; Mariacristina Parravano; Gemma Gatta; Riccardo Capocaccia; Cinzia Mazzini; Sandra Mallone; Laura Botta
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

6.  Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973-2012).

Authors:  Krishnaraj Mahendraraj; Christine Sm Lau; Injoon Lee; Ronald S Chamberlain
Journal:  Clin Ophthalmol       Date:  2016-10-25

7.  Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973-2012).

Authors:  Krishnaraj Mahendraraj; Sneha Shrestha; Christine Sm Lau; Ronald S Chamberlain
Journal:  Clin Ophthalmol       Date:  2017-01-05

8.  Conjunctival melanoma: a review of conceptual and treatment advances.

Authors:  Li-Anne Lim; Michele C Madigan; R Max Conway
Journal:  Clin Ophthalmol       Date:  2013-03-13

9.  High-Dose-Rate Interstitial Brachytherapy (Interventional Radiotherapy) for Conjunctival Melanoma with Orbital Extension.

Authors:  Monica Maria Pagliara; Luca Tagliaferri; Gustavo Savino; Bruno Fionda; Andrea D'Aviero; Angela Lanza; Valentina Lancellotta; Giulia Midena; Maria Antonietta Gambacorta; Maria Antonietta Blasi
Journal:  Ocul Oncol Pathol       Date:  2021-02-17

10.  PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma.

Authors:  Jinfeng Cao; Niels J Brouwer; Kate E Richards; Marina Marinkovic; Sjoerd van Duinen; Daan Hurkmans; Els M E Verdegaal; Ekaterina S Jordanova; Martine J Jager
Journal:  Oncotarget       Date:  2017-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.